Clarification on Tartari et al.: Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients
- PMID: 27649326
- DOI: 10.1016/j.ctrv.2016.08.009
Clarification on Tartari et al.: Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients
Comment on
-
Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challenges.Cancer Treat Rev. 2016 Jul;48:20-4. doi: 10.1016/j.ctrv.2016.06.002. Epub 2016 Jun 7. Cancer Treat Rev. 2016. PMID: 27310708 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
